Trimethoprim-sulfamethoxazole resistance patterns among Staphylococcus aureus in the United States, 2012-2018

Infect Control Hosp Epidemiol. 2023 May;44(5):794-797. doi: 10.1017/ice.2022.9. Epub 2022 Feb 15.

Abstract

We reviewed trimethoprim-sulfamethoxazole antibiotic susceptibility testing data among Staphylococcus aureus using 3 national inpatient databases. In all 3 databases, we observed an increases in the percentage of methicillin-resistant Staphylococcus aureus that were not susceptible to trimethoprim-sulfamethoxazole. Providers should select antibiotic regimens based on local resistance patterns and should report changes to the public health department.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus aureus
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • United States

Substances

  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Anti-Bacterial Agents